glp-1 receptor agonist bcbs Agonists at the Crossroads of Circadian Biology, Sleep, and Metabolic Disease GLP-1 Agonists - What is
Description
How do they work
People on GLP-1s had slightly higher risks of osteoporosis and gout than similar people not taking these drugs
Eli Lilly, makers of weight loss injection Zepbound, could soon be making its GLP-1 drug in pill form.
This performance reflects unprecedented demand despite earlier supply constraints and sets the stage for pricing and reimbursement debates as the market matures
Analysis of nearly 8,000 adults found 45% keep the weight off after one year
Secondary outcomes included time below and above the therapeutic range and INR variability
